Cost-effectiveness of pegfilgrastim versus filgrastim for prevention of chemotherapy-induced febrile neutropenia in patients with lymphoma: a systematic review

BACKGROUND: Febrile neutropenia (FN) is a prevalent and potentially life-threatening complication in patients with lymphoma receiving myelosuppressive chemotherapy. Pegfilgrastim is more effective than filgrastim as prophylaxis for FN. However, its usage has been limited because of its higher cost....

Descripción completa

Detalles Bibliográficos
Autores principales: Gebremariam, Girma Tekle, Fentie, Atalay Mulu, Beyene, Kebede, Sander, Beate, Gebretekle, Gebremedhin Beedemariam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805270/
https://www.ncbi.nlm.nih.gov/pubmed/36585648
http://dx.doi.org/10.1186/s12913-022-08933-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805270/
https://www.ncbi.nlm.nih.gov/pubmed/36585648
http://dx.doi.org/10.1186/s12913-022-08933-z

Ejemplares similares